Patent · US Active

Biomarkers for assessing liver function

US8455220B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2007
Grant dateJun 4, 2013
Priority date
Expiry dateOct 17, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/085
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method for assessing liver function in an individual, which method comprises determining the level of methylarginine(s) (such as ADMA and/or SDMA) and the ratio of ischemia modified albumin (IMA): albumin ratio (IMAR) in the individual, thereby to assess liver function in the individual.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.